PURPLE BIOTECH LTD-ADR(NASDAQ:PPBT) stock News

PPBT Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill - Mentions: NEON DLTH DUO SNTG ...

Unusual volume stocks in Friday's session

3 days ago - By: Chartmill - Mentions: LULU NBY SUPX NVFY ...

Friday's session: top gainers and losers

3 days ago - By: Purple Biotech Ltd.

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants

3 days ago - By: Purple Biotech Ltd.

Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants

3 days ago - By: Benzinga - Mentions: NBY PDEX EQ BBLG ...

12 Health Care Stocks Moving In Friday's Intraday Session

4 days ago - By: Chartmill - Mentions: NBY AEO NEON AEMD ...

Let's take a look at the stocks that are in motion in today's session.

4 days ago - By: Benzinga - Mentions: NBY NKTR IMA AEMD ...

12 Health Care Stocks Moving In Thursday's Intraday Session

4 days ago - By: Chartmill - Mentions: NBY AEO NEON AEMD ...

Top stock movements in today's session.

4 days ago - By: Chartmill - Mentions: NBY AEO SCVL NCI ...

Which stocks are gapping on Thursday?

4 days ago - By: Purple Biotech Ltd.

Purple Biotech Announces Pricing of Up To $18 Million Public Offering

4 days ago - By: Purple Biotech Ltd.

Purple Biotech Announces Pricing of Up To $18 Million Public Offering

5 days ago - By: Purple Biotech Ltd.

Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai

5 days ago - By: Chartmill - Mentions: STI IPDN WVE SSKN ...

Which stocks are moving before the opening bell on Wednesday?

6 days ago - By: Purple Biotech Ltd.

Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2

6 days ago - By: Purple Biotech Ltd.

Purple Biotech Expands CAPTN-3 Portfolio with IM1305, a Novel Tri-Specific Antibody Targeting TROP2

6 days ago - By: Chartmill - Mentions: CYTK UTHR IONS CELU ...

Here are the top movers in Tuesday's session.

6 days ago - By: Chartmill - Mentions: CYTK UTHR ASNS CELU ...

Top movers analysis in the middle of the day on 2025-09-02: top gainers and losers in today's session.

13 days ago - By: Purple Biotech Ltd.

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

13 days ago - By: Purple Biotech Ltd.

Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

a month ago - By: Purple Biotech Ltd.

Purple Biotech Reports Second Quarter 2025 Financial Results

2 months ago - By: Purple Biotech Ltd.

Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025

2 months ago - By: Purple Biotech Ltd.

Purple Biotech CEO Issues Letter to Shareholders Highlighting Pipeline Progress and Clinical Milestones Achieved in First Half of 2025

3 months ago - By: Purple Biotech Ltd.

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

3 months ago - By: Purple Biotech Ltd.

Purple Biotech Highlights Significant Advantages of the Novel CAPTN-3 Tri-Specific Antibody Platform at the EACR 2025 Annual Congress

3 months ago - By: Purple Biotech Ltd.

Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients with Head and Neck Cancer

3 months ago - By: Purple Biotech Ltd.